Gastric Helicobacter infection induces a Th2 phenotype but does not elevate serum cholesterol in mice lacking inducible nitric oxide synthase

Infection and Immunity

Volumn 73, Issue 3, 2005, Pages 1664-1670

  Ihrig, Melanie ^a   Whary, Mark T ^a   Dangler, Charles A ^a   Fox, James G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2C ANTIBODY; INDUCIBLE NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; ATROPHY; BACTERIAL COLONIZATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC GASTRITIS; CONTROLLED STUDY; DISEASE SEVERITY; GENE EXPRESSION REGULATION; GRANULOCYTE; HELICOBACTER FELIS; HELICOBACTER INFECTION; HISTOLOGY; HYPERPLASIA; INFLAMMATION; LYMPHOCYTIC INFILTRATION; METAPLASIA; MOUSE; NONHUMAN; PERSISTENT INFECTION; PHENOTYPE; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH FUNDUS; TH1 CELL; TH2 CELL; WILD TYPE; ANIMAL; BLOOD; C57BL MOUSE; FEMALE; GASTRITIS; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOGENICITY; PATHOLOGY; STOMACH;

ANIMALS; ANTIBODIES, BACTERIAL; CHOLESTEROL; FEMALE; GASTRITIS; HELICOBACTER FELIS; HELICOBACTER INFECTIONS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; SPECIFIC PATHOGEN-FREE ORGANISMS; STOMACH; TH2 CELLS;

EID: 15544372507     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.3.1664-1670.2005     Document Type: Article

References (49)

1. Bauer, H., T. Jung, D. Tsikas, D. O. Stichtenoth, J. C. Frolich, and C. Neumann. 1997. Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology 90:205-211.
2. Blanchard, T. G., and S. J. Czinn. 1998. Immunological determinants that may affect the Helicobacter pylon cancer risk. Aliment. Pharmacol. Ther. 12(Suppl. 1):83-90.
3. Chimienti, G., F. Russo, B. L. Lamanuzzi, M. Nardulli, C. Messa, A. Di Leo, M. Correale, V. Giannuzzi, and G. Pepe. 2003. Helicobacter pylori is associated with modified lipid profile: impact on lipoprotein(a). Clin. Biochem. 36:359-365.
4. Coleman, J. W. 2001. Nitric oxide in immunity and inflammation. Int. Immunopharmacol. 1:1397-1406.
5. Court, M., P. A. Robinson, M. F. Dixon, A. H. Jeremy, and J. E. Crabtree. 2003. The effect of gender on Helicobacter felis-mediated gastritis, epithelial cell proliferation, and apoptosis in the mouse model. J. Pathol. 201:303-311.
6. Danesh, J., J. Koreth, L. Youngman, R. Collins, J. R. Arnold, Y. Balarajan, J. McGee, and D. Roskell. 1999. Is Helicobacter pylori a factor in coronary atherosclerosis? J. Clin. Microbiol. 37:1651.
7. Danesh, J., and R. Peto. 1998. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 316:1130-1132.
8. Ernst, P. 1999. The role of inflammation in the pathogenesis of gastric cancer. Aliment. Pharmacol. Ther. 13(Suppl. 1):13-18.
9. Felley, C. P., B. Pignatelli, G. D. Van Melle, J. E. Crabtree, M. Stolte, J. Diezi, I. Corthesy-Theulaz, P. Michetti, B. Bancel, L. M. Patricot, H. Ohshima, and E. Felley-Bosco. 2002. Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication. Helicobacter 7:342-348.
10. Folsom, A. R., F. J. Nieto, P. Sorlie, L. E. Chambless, D. Y. Graham, et al. 1998. Helicobacter pylori seropositivity and coronary heart disease incidence. Circulation 98:845-850.
11. Fox, J. G., P. Beck, C. A. Dangler, M. T. Whary, T. C. Wang, H. N. Shi, and C. Nagler-Anderson. 2000. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat. Med. 6:536-542.
12. Fox, J. G., X. Li, R. J. Cahill, K. Andrutis, A. K. Rustgi, R. Odze, and T. C. Wang. 1996. Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology 110:155-166.
13. Fox, J. G., A. B. Rogers, M. Ihrig, N. S. Taylor, M. T. Whary, G. Dockray, A. Varro, and T. C. Wang. 2003. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res. 63:942-950.
14. Fox, J. G., B. J. Sheppard, C. A. Dangler, M. T. Whary, M. Ihrig, and T. C. Wang. 2002. Germ-line p53-targeted disruption inhibits helicobacter-induced premalignant lesions and invasive gastric carcinoma through down-regulation of Th1 proinflammatory responses. Cancer Res. 62:696-702.
15. Goto, T., K. Haruma, Y. Kitadai, M. Ito, M. Yoshihara, K. Sumii, N. Hayakawa, and G. Kajiyama. 1999. Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin. Cancer Res. 5:1411-1415.
16. Guiney, D. G., P. Hasegawa, and S. P. Cole. 2003. Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect. Immun. 71:4163-4166.
17. Holan, V., M. Krulova, A. Zajicova, and J. Pindjakova. 2002. Nitric oxide as a regulatory and effector molecule in the immune system. Mol. Immunol. 38:989-995.
18. Holck, S., A. Norgaard, M. Bennedsen, H. Permin, S. Norn, and L. P. Andersen. 2003. Gastric mucosal cytokine responses in Helicobacier pylori-infected patients with gastritis and peptic ulcers. Association with inflammatory parameters and bacteria load. FEMS Immunol. Med. Microbiol. 36:175-180.
19. Ihrig, M., C. A. Dangler, and J. G. Fox. 2001. Mice lacking inducible nitric oxide synthase develop spontaneous hypercholesterolaemia and aortic atheromas. Atherosclerosis 156:103-107.
20. Ismail, H. F., P. Pick, J. Zhang, R. G. Lynch, and D. J. Berg. 2003. Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J. Immunol. 170:3782-3789.
21. Kaise, M., J. Miwa, K. Iihara, N. Suzuki, Y. Oda, and Y. Ohta. 2003. Helicobacter pylori stimulates inducible nitric oxide synthase in diverse topographical patterns in various gastroduodenal disorders. Dig. Dis. Sci. 48:636-643.
22. Kroncke, K. D., K. Fehsel, C. Suschek, and V. Kolb-Bachofen. 2001. Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int. Immunopharmacol. 1:1407-1420.
23. Laurila, A., A. Bloigu, S. Nayha, J. Hassi, M. Leinonen, and P. Saikku. 1999. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 142:207-210.
24. Li, C. Q., B. Pignatelli, and H. Ohshima. 2001. Increased oxidative and nitrative stress in human stomach associated with cagA+ Helicobacter pylori infection and inflammation. Dig. Dis. Sci. 46:836-844.
25. Li, H., C. Stoicov, X. Cai, T. C. Wang, and J. Houghton. 2003. Helicobacter and gastric cancer disease mechanisms: host response and disease susceptibility. Curr. Gastroenterol. Rep. 5:459-467.
26. Martin, R. M., J. L. Brady, and A. M. Lew. 1998. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Methods 212:187-192.
27. Mendall, M. A., P. M. Goggin, N. Molineaux, J. Levy, T. Toosy, D. Strachan, A. J. Camm, and T. C. Northfield. 1994. Relation of Helicobacter pylori infection and coronary heart disease. Br. Heart J. 71:437-439.
28. Miyazawa, M., H. Suzuki, T. Masaoka, A. Kai, M. Suematsu, H. Nagata, S. Miura, and H. Ishii. 2003. Suppressed apoptosis in the inflamed gastric mucosa of Helicobacter pylori-colonized iNOS-knockout mice. Free Radic. Biol. Med. 34:1621-1630.
29. Nagata, K., H. Yu, M. Nishikawa, M. Kashiba, A. Nakamura, E. F. Sato, T. Tamura, and M. Inoue. 1998. Helicobacter pylori generates superoxide radicals and modulates nitric oxide metabolism. J. Biol. Chem. 273:14071-14073.
30. Nam, K. T., S. Y. Oh, B. Ahn, Y. B. Kim, D. D. Jang, K. H. Yang, K. B. Hahm, and D. Y. Kim. 2004. Decreased Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide synthase. Gut 53:1250-1255.
31. Nardone, G. 2003. Review article: molecular basis of gastric carcinogenesis. Aliment. Pharmacol. Ther. 17(Suppl. 2):75-81.
32. Neu, B., A. J. Puschmann, A. Mayerhofer, P. Hutzler, J. Grossmann, F. Lippl, W. Schepp, and C. Prinz. 2003. TNF-alpha induces apoptosis of parietal cells. Biochem. Pharmacol. 65:1755-1760.
33. Neureiter, D., P. Heuschmann, S. Stintzing, P. Kolominsky-Rabas, L. Barbera, A. Jung, M. Ocker, M. Maass, G. Faller, and T. Kirchner. 2003. Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate. Atherosclerosis 168:153-162.
34. Obonyo, M., D. G. Guiney, J. Fierer, and S. P. Cole. 2003. Interactions between inducible nitric oxide and other inflammatory mediators during Helicobacter pylori infection. Helicobacter 8:495-502.
35. Obonyo, M., D. G. Guiney, J. Harwood, J. Fierer, and S. P. Cole. 2002. Role of gamma interferon in Helicobacter pylori induction of inflammatory mediators during murine infection. Infect. Immun. 70:3295-3299.
36. Pilotto, A., F. Rumor, M. Franceschi, G. Leandro, R. Novelle, G. Soffiati, M. Scagnelli, F. Di Mario, and G. Valerio. 1999. Lack of association between Helicobacter pylori infection and extracardiac atherosclerosis in dyspeptic elderly subjects. Age Ageing 28:367-371.
37. Rajnakova, A., P. M. Goh, S. T. Chan, S. S. Ngoi, A. Alponat, and S. Moochhala. 1997. Expression of differential nitric oxide synthase isoforms in human normal gastric mucosa and gastric cancer tissue. Carcinogenesis 18:1841-1845.
38. Rogers, A. B., and J. G. Fox. 2004. Inflammation and Cancer. I. Rodent models of infectious gastrointestinal and liver cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 286:361-366.
39. Roth, K. A., S. B. Kapadia, S. M. Martin, and R. G. Lorenz. 1999. Cellular immune responses are essential for the development of Helicobacter felis-associated gastric pathology. J. Immunol. 163:1490-1497.
40. Sakaguchi, A. A., S. Miura, T. Takeuchi, R. Hokari, M. Mizumori, H. Yoshida, H. Higuchi, M. Mori, H. Kimura, H. Suzuki, and H. Ishii. 1999. Increased expression of inducible nitric oxide synthase and peroxynitrite in Helicobacter pylori gastric ulcer. Free Radic. Biol. Med. 27:781-789.
41. Scharnagl, H., M. Kist, A. B. Grawitz, W. Koenig, H. Wieland, and W. Marz. 2004. Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol. Am. J. Cardiol. 93:219-220.
42. Schreiber, S., M. Stüben, C. Josenhans, P. Scheid, and S. Suerbaum. 1999. In vivo distribution of Helicobacter felis in the gastric mucus of the mouse: experimental method and results. Infect. Immun. 67:5151-5156.
43. Son, H. J., J. C. Rhee, D. I. Park, Y. H. Kim, P. L. Rhee, K. C. Koh, S. W. Paik, K. W. Choi, and J. J. Kim. 2001. Inducible nitric oxide synthase expression in gastroduodenal diseases infected with Helicobacter pylori. Helicobacter 6:37-43.
44. Strachan, D. P., M. A. Mendall, D. Carrington, B. K. Butland, J. W. Yarnell, P. M. Sweetnam, and P. C. Elwood. 1998. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the Caerphilly prospective heart disease study. Circulation 98:1286-1290.
45. Wald, N. J., M. R. Law, J. K. Morris, and A. M. Bagnall. 1997. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ 315:1199-1201.
46. Walker, M. M., and J. E. Crabtree. 1998. Helicobacter pylori infection and the pathogenesis of duodenal ulceration. Ann. N. Y. Acad. Sci. 859:96-111.
47. Wang, S., W. Wang, R. A. Wesley, and R. L. Danner. 1999. A Sp1 binding site of the tumor necrosis factor alpha promoter functions as a nitric oxide response element. J. Biol. Chem. 274:33190-33193.
48. Whary, M. T., and J. G. Fox. 2004. Th1-mediated pathology in mouse models of human disease is ameliorated by concurrent Th2 responses to parasite antigens. Curr. Top. Med. Chem. 4:531-538.
49. Zhang, X. J., J. H. Thompson, E. E. Mannick, P. Correa, and M. J. Miller. 1998. Localization of inducible nitric oxide synthase mRNA in inflamed gastrointestinal mucosa by in situ reverse transcriptase-polymerase chain reaction. Nitric Oxide 2:187-192.